Aprea Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Aprea Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2018 to Q3 2024.
  • Aprea Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $149K, a 96.1% increase year-over-year.
  • Aprea Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $4.98M, a 270% increase from 2019.
  • Aprea Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2019 was $1.35M, a 308% increase from 2018.
  • Aprea Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2018 was $330K, a 16.6% decline from 2017.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $149K +$73.1K +96.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $128K -$141K -52.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $85.8K +$69.6K +428% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q3 2023 $76K +$37.8K +98.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $269K -$14.5M -98.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $16.2K -$2.08M -99.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q3 2022 $38.2K -$2M -98.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $14.8M +$12.9M +694% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $2.1M +$277K +15.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q3 2021 $7.15M $2.04M +$647K +46.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $6.51M $1.86M +$607K +48.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $5.9M $1.82M +$917K +101% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $4.98M $1.43M +$617K +75.7% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-16
Q3 2020 $4.37M $1.39M +$1.14M +464% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $3.22M $1.26M +$1.07M +572% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $2.15M $905K +$808K +824% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $1.35M $815K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-16
Q3 2019 $246K +$166K +209% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $187K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 $97.9K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q3 2018 $79.8K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.